Fluorescein Angiography (FA)

What is fluorescein angiography and what it studies

Fundus fluorescein angiography (FA) uses a dye (fluorescein) usually given intravenously. The substance circulates in the bloodstream and is illuminated with suitable light in the retina, allowing filling phases of the vessels and areas with abnormal leakage or blocked flow to be recorded.

Unlike a single static photograph, FA follows time: early images show the arterial and venous phase, while later images reveal dye leakage into the tissue or accumulation. This is why it remains useful when exactly this dynamic information is needed, beyond the thickness or structure provided by optical coherence tomography.

Interpretation requires familiarity with the phases of the angiogram. Incomplete dilation, eye movement, or significant haze of the optical media can reduce quality. When findings do not "match" the clinical picture, repetition or complementary imaging is discussed so decisions are not based on a single incomplete capture.

Indications and clinical scenarios

Within retina and macula diseases, FA is indicated selectively when the clinical picture or OCT is not enough to determine the nature of a lesion, the extent of a leak, or the need for intravitreal treatment or argon laser photocoagulation.

• Wet age-related macular degeneration and suspected neovascular patterns
• Diabetic retinopathy with suspected leakage or ischaemia
• Vascular occlusions and associated oedema
• Inflammatory conditions requiring mapping of vascular leakage

The decision on "FA now or later" depends on the urgency of the problem, prior imaging, and whether sufficient data has already been obtained by other methods.

In chronic conditions, FA may be repeated for monitoring, always in moderation: giving dye is not "risk-free routine" for everyone, which is why the frequency and necessity are discussed individually. Coordination with the treating physician regarding blood sugar, blood pressure and kidney function helps reduce unnecessary risk.

Preparation, procedure and safety

Before the test, a history of allergies, heart or kidney conditions, and current medication is recorded; fluorescein is generally well tolerated, but rare allergic reactions exist and the procedure is carried out with appropriate supervision. Dilation is often given for a full view of the fundus; after dilation, near vision and light sensitivity may be temporarily reduced, so driving is not recommended for several hours.

During administration you may feel a cool sensation at the injection site; afterwards the skin and urine may turn temporarily yellow due to the dye. Nausea or dizziness occur in a small proportion of patients and should be reported to staff if they worsen.

Those with a history of severe allergy or significantly limited heart or kidney function should inform their ophthalmologist before scheduling; in some cases alternative tests or special monitoring are preferred. Pregnant and breastfeeding patients should discuss risk and benefit with their doctor before any intravenous administration.

Relationship with OCT, OCTA and digital photography

OCT and OCTA give detailed structure and vascular patterns without a dye injection; FA remains useful when a dynamic study of leakage and a time sequence is needed. The three methods often complement each other and do not "replace" the clinical examination at the comprehensive check-up.

Digital fundus photography archives the surface image, FA adds functional vascular information. After treatment, repeating tests is organised by the ophthalmologist so findings can be compared over time.

In many scenarios, OCTA reduces the need for FA, but when dynamic proof of leakage or detailed mapping in inflammation is needed, FA remains part of the toolkit. The choice is not "fashion" but a clinical decision based on the question that needs answering.

After the test and next steps

The ophthalmologist discusses the findings within the overall plan: whether monitoring, an injection, laser, or simply a follow-up check is needed. When vision for driving or fine tasks changes, refraction and glasses may be reassessed once the condition has stabilised.

For an overview of tests and services: services; for appointments and clarifications: contact. Bring your list of medications and previous imaging, so comparisons over time are as complete as possible.